Evaluation of the effect of carrier material on modification of release characteristics of poor water soluble drug from liquisolid compacts

Liquisolid compact is a novel dosage form in which a liquid medication (liquid drug, drug solution/dispersion in non-volatile solvent/solvent system) is converted to a dry, free flowing powder and compressed. Objective of the study was to elucidate the effect of carrier material on release characteristics of clopidogrel from liquisolid compacts. Different formulations of liquisolid compacts were developed using microcrystalline cellulose, starch maize, polyvinyl pyrollidone and hydroxypropyl methylcellulose as carrier material in three concentrations (40, 30 and 20%, w/w). Liquid vehicle was selected on the basis of solubility of clopidogrel. Colloidal silicondioxide was used as coating material and ratio of carrier to coating material was kept 10. A control formulation comprised of microcrystalline cellulose (diluents), tabletose-80 (diluents), primojel (disintegrant) and magnesium stearate (lubricant) was prepared by direct compression technique and was used for comparison. All the formulations were evaluated at pre and post compression level. Acid solubility profile showed higher solubility in HCl buffer pH2 (296.89±3.49 μg/mL). Mixture of propylene glycol and water (2:1, v/v) was selected as liquid vehicle. Drug content was in the range of 99–101% of the claimed quantity. All the formulations showed better mechanical strength and their friability was within the official limits (<1%). Microcrystalline cellulose and starch maize resulted in faster drug release while polyvinyl pyrollidone and HPMC resulted in sustaining drug release by gel formation. It is concluded from results that both fast release and sustained release of clopidogrel can be achieved by proper selection of carrier material.

[1]  T. Aparna LIQUISOLID COMPACTS: AN APPROACH TO ENHANCE THE DISSOLUTION RATE OF DOMPERIDONE , 2017 .

[2]  Tianzhi Yang,et al.  Liquisolid technique and its applications in pharmaceutics , 2016, Asian journal of pharmaceutical sciences.

[3]  A. Samanta,et al.  Overview of milling techniques for improving the solubility of poorly water-soluble drugs , 2015 .

[4]  Zia Ullah,et al.  Enhancement of dissolution rate of class II drugs (Hydrochlorothiazide); a comparative study of the two novel approaches; solid dispersion and liqui-solid techniques , 2015, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.

[5]  E. Antman,et al.  PON1 Q192R genetic variant and response to clopidogrel and prasugrel: pharmacokinetics, pharmacodynamics, and a meta-analysis of clinical outcomes , 2015, Journal of Thrombosis and Thrombolysis.

[6]  A. Deshpande,et al.  CO-CRYSTALLIZATION- A TECHNIQUE FOR SOLUBILITY ENHANCEMENT , 2014 .

[7]  D. Do,et al.  Brief Overview of Various Approaches to Enhance Drug Solubility , 2013 .

[8]  D. Danielak,et al.  Clinical Pharmacokinetics of Clopidogrel and Its Metabolites in Patients with Cardiovascular Diseases , 2013, Clinical Pharmacokinetics.

[9]  R. Rowe Handbook of Pharmaceutical Excipients – 7th Edition , 2013 .

[10]  Y. Gavhane,et al.  Loss of orally administered drugs in GI tract. , 2012, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.

[11]  M. Veiga,et al.  Matrix Tablets: The Effect of Hydroxypropyl Methylcellulose/Anhydrous Dibasic Calcium Phosphate Ratio on the Release Rate of a Water-Soluble Drug Through the Gastrointestinal Tract I. In Vitro Tests , 2012, AAPS PharmSciTech.

[12]  K. Srinivasan,et al.  Influence of formulation parameters on dissolution rate enhancement of glyburide using liquisolid technique , 2012, Drug development and industrial pharmacy.

[13]  I. Smirnova,et al.  Enhancement of griseofulvin release from liquisolid compacts. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[14]  S. Shanmugam,et al.  New clopidogrel napadisilate salt and its solid dispersion with improved stability and bioequivalence to the commercial clopidogrel bisulphate salt in beagle dogs. , 2011, International journal of pharmaceutics.

[15]  Russ B Altman,et al.  Platelet aggregation pathway. , 2011, Pharmacogenetics and genomics.

[16]  M. Umekar,et al.  Solubility enhancement studies of hydrochlorothiazide by preparing soliddispersions using losartan potassium and urea by different methods , 2011 .

[17]  Cary E. Johnson,et al.  Stability of an extemporaneously prepared clopidogrel oral suspension. , 2010, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[18]  A. Elkordy,et al.  Liquisolid Systems to Improve the Dissolution of Furosemide , 2010, Scientia pharmaceutica.

[19]  A H Hosmani,et al.  Evaluation of in vitro dissolution profile comparison methods of sustained release tramadol hydrochloride liquisolid compact formulations with marketed sustained release tablets. , 2010, Drug discoveries & therapeutics.

[20]  R. Altman,et al.  Clopidogrel pathway. , 2010, Pharmacogenetics and genomics.

[21]  G. Keller,et al.  Bioequivalence of two tablet formulations of clopidogrel in healthy Argentinian volunteers: a single-dose, randomized-sequence, open-label crossover study. , 2010, Clinical therapeutics.

[22]  N. Tiong,et al.  Effects of liquisolid formulations on dissolution of naproxen. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[23]  A. Yadav,et al.  Improvement of Solubility and Dissolution of Indomethacin by Liquisolid and Compaction Granulation Technique , 2009 .

[24]  Yousef Javadzadeh,et al.  Liquisolid technique as a new approach to sustain propranolol hydrochloride release from tablet matrices. , 2008, International journal of pharmaceutics.

[25]  M. Kassem,et al.  Enhancement of famotidine dissolution rate through liquisolid tablets formulation: in vitro and in vivo evaluation. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[26]  Saadia A Tayel,et al.  Improvement of dissolution properties of Carbamazepine through application of the liquisolid tablet technique. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[27]  J. L. S. Sobrinho,et al.  Alternative technologies to improve solubility of poorly water soluble drugs , 2008 .

[28]  Yousef Javadzadeh,et al.  Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine). , 2007, International journal of pharmaceutics.

[29]  K. Winters,et al.  Cytochrome P450 3A Inhibition by Ketoconazole Affects Prasugrel and Clopidogrel Pharmacokinetics and Pharmacodynamics Differently , 2007, Clinical pharmacology and therapeutics.

[30]  A. Nokhodchi,et al.  Enhancement of dissolution rate of piroxicam using liquisolid compacts. , 2005, Farmaco.

[31]  P. Costa,et al.  Modeling and comparison of dissolution profiles. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[32]  R. Grover,et al.  In vitro release evaluation of hydrocortisone liquisolid tablets. , 1998, Journal of pharmaceutical sciences.

[33]  Spiro Spireas,et al.  Enhancement of prednisolone dissolution properties using liquisolid compacts , 1998 .